Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Integra Lifesciences Holdings (IART) Interest Expenses (2016 - 2025)

Historic Interest Expenses for Integra Lifesciences Holdings (IART) over the last 17 years, with Q3 2025 value amounting to $22.7 million.

  • Integra Lifesciences Holdings' Interest Expenses rose 1730.24% to $22.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $81.6 million, marking a year-over-year increase of 2472.06%. This contributed to the annual value of $70.6 million for FY2024, which is 3747.79% up from last year.
  • Integra Lifesciences Holdings' Interest Expenses amounted to $22.7 million in Q3 2025, which was up 1730.24% from $21.0 million recorded in Q2 2025.
  • In the past 5 years, Integra Lifesciences Holdings' Interest Expenses registered a high of $22.7 million during Q3 2025, and its lowest value of $11.7 million during Q1 2022.
  • In the last 5 years, Integra Lifesciences Holdings' Interest Expenses had a median value of $13.1 million in 2023 and averaged $15.0 million.
  • As far as peak fluctuations go, Integra Lifesciences Holdings' Interest Expenses plummeted by 4137.33% in 2021, and later surged by 4963.9% in 2024.
  • Integra Lifesciences Holdings' Interest Expenses (Quarter) stood at $12.1 million in 2021, then grew by 6.34% to $12.9 million in 2022, then rose by 6.65% to $13.8 million in 2023, then soared by 38.06% to $19.0 million in 2024, then increased by 19.71% to $22.7 million in 2025.
  • Its last three reported values are $22.7 million in Q3 2025, $21.0 million for Q2 2025, and $18.8 million during Q1 2025.